Search research articles
Contact Us
Filters
Showing results (321-330 of 359) with videos related to
Page
of 36
Sort By:
Proceedings of the National Academy of Sciences of the United States of America
|
February 2, 2026
Next-generation anti-DLL3 radiopharmaceuticals targeting high-grade neuroendocrine lung and prostate cancers
Salomon Tendler, Roberto De Gregorio, Paul Balderes, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
March 15, 2020
First-in-Humans Trial of Dasatinib-Derivative Tracer for Tumor Kinase-Targeted PET
Simone Krebs, Darren R Veach, Lukas M Carter, et al.
The Lancet. Oncology
|
May 31, 2024
Recent advances and impending challenges for the radiopharmaceutical sciences in oncology
Suzanne E Lapi, Peter J H Scott, Andrew M Scott, et al.
Inorganic Chemistry
|
February 1, 2023
Sc-HOPO: A Potential Construct for Use in Radioscandium-Based Radiopharmaceuticals
Michael D Phipps, Shelbie Cingoranelli, N V S Dinesh K Bhupathiraju, et al.
Nature Cancer
|
April 10, 2023
Landscape of prostate-specific membrane antigen heterogeneity and regulation in AR-positive and AR-negative metastatic prostate cancer
Martin K Bakht, Yasutaka Yamada, Sheng-Yu Ku, et al.
JAMA Oncology
|
November 10, 2017
Positron Emission Tomography/Computed Tomography-Based Assessments of Androgen Receptor Expression and Glycolytic Activity as a Prognostic Biomarker for Metastatic Castration-Resistant Prostate Cancer
Josef J Fox, Somali C Gavane, Estelle Blanc-Autran, et al.
Science Translational Medicine
|
February 13, 2015
Glutamine-based PET imaging facilitates enhanced metabolic evaluation of gliomas in vivo
Sriram Venneti, Mark P Dunphy, Hanwen Zhang, et al.
Radiology
|
February 2, 2018
In Vivo PET Assay of Tumor Glutamine Flux and Metabolism: In-Human Trial of <sup>18</sup>F-(2S,4R)-4-Fluoroglutamine
Mark P S Dunphy, James J Harding, Sriram Venneti, et al.
Bioconjugate Chemistry
|
May 17, 2019
Multimodal Positron Emission Tomography Imaging to Quantify Uptake of <sup>89</sup>Zr-Labeled Liposomes in the Atherosclerotic Vessel Wall
Mark E Lobatto, Tina Binderup, Philip M Robson, et al.
Cancer Research
|
May 11, 2017
Noninvasive Interrogation of DLL3 Expression in Metastatic Small Cell Lung Cancer
Sai Kiran Sharma, Jacob Pourat, Dalya Abdel-Atti, et al.
Page
of 36
Search research articles
Search
Showing results (321-330 of 359) with videos related to
Sort By:
Page
of 36
Proceedings of the National Academy of Sciences of the United States of America
|
February 2, 2026
Next-generation anti-DLL3 radiopharmaceuticals targeting high-grade neuroendocrine lung and prostate cancers
Salomon Tendler, Roberto De Gregorio, Paul Balderes, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
March 15, 2020
First-in-Humans Trial of Dasatinib-Derivative Tracer for Tumor Kinase-Targeted PET
Simone Krebs, Darren R Veach, Lukas M Carter, et al.
The Lancet. Oncology
|
May 31, 2024
Recent advances and impending challenges for the radiopharmaceutical sciences in oncology
Suzanne E Lapi, Peter J H Scott, Andrew M Scott, et al.
Inorganic Chemistry
|
February 1, 2023
Sc-HOPO: A Potential Construct for Use in Radioscandium-Based Radiopharmaceuticals
Michael D Phipps, Shelbie Cingoranelli, N V S Dinesh K Bhupathiraju, et al.
Nature Cancer
|
April 10, 2023
Landscape of prostate-specific membrane antigen heterogeneity and regulation in AR-positive and AR-negative metastatic prostate cancer
Martin K Bakht, Yasutaka Yamada, Sheng-Yu Ku, et al.
JAMA Oncology
|
November 10, 2017
Positron Emission Tomography/Computed Tomography-Based Assessments of Androgen Receptor Expression and Glycolytic Activity as a Prognostic Biomarker for Metastatic Castration-Resistant Prostate Cancer
Josef J Fox, Somali C Gavane, Estelle Blanc-Autran, et al.
Science Translational Medicine
|
February 13, 2015
Glutamine-based PET imaging facilitates enhanced metabolic evaluation of gliomas in vivo
Sriram Venneti, Mark P Dunphy, Hanwen Zhang, et al.
Radiology
|
February 2, 2018
In Vivo PET Assay of Tumor Glutamine Flux and Metabolism: In-Human Trial of <sup>18</sup>F-(2S,4R)-4-Fluoroglutamine
Mark P S Dunphy, James J Harding, Sriram Venneti, et al.
Bioconjugate Chemistry
|
May 17, 2019
Multimodal Positron Emission Tomography Imaging to Quantify Uptake of <sup>89</sup>Zr-Labeled Liposomes in the Atherosclerotic Vessel Wall
Mark E Lobatto, Tina Binderup, Philip M Robson, et al.
Cancer Research
|
May 11, 2017
Noninvasive Interrogation of DLL3 Expression in Metastatic Small Cell Lung Cancer
Sai Kiran Sharma, Jacob Pourat, Dalya Abdel-Atti, et al.
Page
of 36